Status
Conditions
About
This study aims to evaluate the impact of AbbVie Care 2.0 on adalimumab's compliance, patient reported outcomes and utilization of health resources over 12 months.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
AbbVie Care 2.0 Cohort-specific inclusion criteria:
Exclusion criteria
116 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal